Literature DB >> 9597935

Can adrenal incidentalomas be safely observed?

M K Barry1, J A van Heerden, D R Farley, C S Grant, G B Thompson, D M Ilstrup.   

Abstract

We currently recommend excision of adrenal incidentalomas > or = 4 cm in size and all hormonally active tumors. The optimal management and follow-up of smaller nonfunctioning tumors are controversial. The aim of this study was to determine the clinical outcome of a well defined population of patients with incidentalomas followed without operative intervention. The study group comprised 231 patients, identified from the records of abdominal or thoracic computed tomographic (CT) scans performed between 1985 and 1989. The primary outcome variable analyzed was survival. Follow-up was obtained by office records, telephone contact, or letter. There were 101 male and 130 female patients with a mean age at diagnosis of 64 years (range 5-86 years). Most adrenal tumors were unilateral (right 113; left 98); 20 were bilateral. Mean tumor size was 2 cm (range 1-6 cm). In nine (4%) patients the tumor was > or = 4 cm. Follow-up [mean 7 years; range 1 month (patient died) to 11.7 years] was complete in 224 (97%) patients. Ninety-one (39%) patients had one or more additional CT scans performed during the follow-up period, with only four patients demonstrating a > 1 cm increase in the size of the adrenal mass. Surgical excision of these four lesions identified benign pathology. Eighty-one (35%) patients died of conditions unrelated to adrenal pathology. No patient developed subsequent adrenal hyperfunction or adrenal malignancy. Within the context of our guidelines, conservative management of adrenal incidentalomas considered benign or nonfunctioning at diagnosis is appropriate. Additional information provided by repeat CT scanning appears to confer limited benefit. This study does not support laparoscopic removal of small, nonfunctional adrenal tumors, as has been suggested.

Entities:  

Mesh:

Year:  1998        PMID: 9597935     DOI: 10.1007/s002689900441

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  13 in total

1.  The influence of new technologies on laparoscopic adrenalectomy: our personal experience with 91 patients.

Authors:  A Valeri; A Borrelli; L Presenti; M Lucchese; G Manca; P Tonelli; C Bergamini; D Borrelli; M Palli; C Saieva
Journal:  Surg Endosc       Date:  2002-05-07       Impact factor: 4.584

Review 2.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

3.  The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.

Authors:  E Grossrubatscher; F Vignati; M Possa; P Lohi
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

4.  Guidelines for the management of the incidentally discovered adrenal mass.

Authors:  Anil Kapoor; Topher Morris; Ryan Rebello
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

Review 5.  Subclinical Cushing's syndrome.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Silvia Bovio; Alberto Angeli
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

Review 6.  Adrenal masses: the investigation and management of adrenal incidentalomas.

Authors:  H R Patel; A M Harris; T W Lennard
Journal:  Ann R Coll Surg Engl       Date:  2001-07       Impact factor: 1.891

7.  Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Database.

Authors:  Alexander Kutikov; Katherine Mallin; Daniel Canter; Yu-Ning Wong; Robert G Uzzo
Journal:  J Urol       Date:  2011-07-23       Impact factor: 7.450

8.  Adrenal incidentalomas: experience in a developing country.

Authors:  P R K Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

9.  Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas.

Authors:  S Yener; S Ertilav; M Secil; T Demir; B Akinci; L Kebapcilar; A Comlekci; F Bayraktar; S Yesil
Journal:  J Endocrinol Invest       Date:  2009-06-18       Impact factor: 4.256

10.  Effectiveness of partial adrenalectomy for concomitant hypertension in patients with nonfunctional adrenal adenoma.

Authors:  Tianyuan Xu; Leilei Xia; Xianjin Wang; Xiaohua Zhang; Shan Zhong; Liang Qin; Xiang Zhang; Yu Zhu; Zhoujun Shen
Journal:  Int Urol Nephrol       Date:  2014-10-11       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.